CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- 4 Grant or award Director acquired 791 shares (grant or award)
- 4 Grant or award Director acquired 791 shares (grant or award)
- 4 Gift President & CEO gave 25,000 shares (gift)
- 4 Grant or award Director acquired 16,745 shares (grant or award)
- 4 Grant or award Director acquired 16,745 shares (grant or award)
- 4 Grant or award Director acquired 16,745 shares (grant or award)
- 4 Grant or award Director acquired 16,745 shares (grant or award)
- 4 Open-market sale Director sold 4,000 shares at $7.98 ($31,920)
- 4 Grant or award Director acquired 16,745 shares (grant or award)
- 4 Open-market sale Director sold 12,866 shares at $8.04 ($103,443)
- 4 Grant or award Director acquired 16,745 shares (grant or award)
- 4 Grant or award Director acquired 16,745 shares (grant or award)
- 4 Grant or award Director acquired 16,745 shares (grant or award)
- 4 Grant or award Director acquired 680 shares (grant or award)
- 4 Grant or award Director acquired 1,360 shares (grant or award)
- 4 Grant or award Director acquired 680 shares (grant or award)
- 4 Planned sale Chief R&D Officer sold 7,000 shares at $8.29 ($58,030)
- 4 Exercise or conversion President & CEO acquired 31,055 shares (option exercise)
- 4 Grant or award Director acquired 635 shares (grant or award)
- 4 Grant or award Director acquired 2,259 shares (grant or award)
Page 7 of 49 · 965 filings